Please assess the completion status of the following clinical trial:

Trial Title: Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. ≥ 18 years old.~2. Medical record documentation of either: a) a current diagnosis or history of recurrent CDI as determined by the treating physician, b) or has had at least two episodes of severe CDI resulting in hospitalization.~3. Is currently taking or was just prescribed antibiotics to control CDI related diarrhea at the time of enrollment. \[Note: Subject's CDI diarrhea must be controlled (\<3 unformed/loose stools/day) while taking antibiotics during screening.\]~Exclusion Criteria:~1. Has continued CDI diarrhea despite being on a course of antibiotics prescribed for CDI treatment.~2. Requires systemic antibiotic therapy for a condition other than CDI.~3. Fecal microbiota transplant (FMT) within the past 6 months.~4. FMT with an associated serious adverse event related to the FMT product or procedure.~5. Bezlotoxumab (CDI monoclonal antibodies) if received within the last year.~6. CD4 count \<200/mm\^3 during Screening.~7. An absolute neutrophil count of \<1000 cells/µL during Screening.~8. Pregnant, breastfeeding, or intends to become pregnant during study participation.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Active (Type: EXPERIMENTAL): RBX2660 is an enema of a microbiota suspension

Based on this trial design, predict the completion outcome and termination type (if applicable).